Article Listing - Actelion nominates Garnier and Bertolini to board; UK’s ABPI names industry outside as new CEO

GERMAN PANEL DOCTOR NUMBERS

13 April 1992

The rate of rise in the number of doctors in public-sector general practice registering in Germany is growing, says the...

FORTHCOMING MEETINGS FROM IBC

13 April 1992

IBC Technical Services Ltd is organizing the following industry-related conferences over the next few months:

- Strategies, Costs and Timing: The...

NET PROFITS UP 41% AT SYNTHELABO

13 April 1992

French health care group Synthelabo reported consolidated turnover in 1991 up 8.1% on 1990 at 3.45 billion French francs ($618.8...

STRONG EXPANSION AT KNOLL IN 1991

13 April 1992

The drug-making arm of the German chemical concern BASF, Knoll AG, has reported a 9% expansion of sales worldwide...

NOVO-NORDISK'S rec INSULIN LAUNCHED IN FRANCE

13 April 1992

Novo-Nordisk has launched four formulations of its recombinant human insulin under the trade name Mixtard HMge Penfill. All the formulations...

BIOCRAFT BOOSTED BY APPROVALS

13 April 1992

The US pharmaceutical concern Biocraft Laboratories has been boosted in the first quarter of the current year by approvals from...

IDEC PHARMA'S ANTIBODY THERAPY

13 April 1992

IDEC Pharmaceuticals reports that it has developed a "primatized" antibody which could improve the treatment of several chronic diseases. The...

S-P HEALTHCARE PRODUCTS CANADA

13 April 1992

At Schering-Plough Health-Care Products Canada Inc, George Cugini moves up to vice president, marketing, from marketing director, seasonal products. Dan...

ISRAEL'S YISSUM R&D CO CLAIMS ACHIEVEMENTS

13 April 1992

Yissum is Israel's leading university R&D company, the Marketletter's local correspondent notes, and it offers more than 150 applied research...

FUJISAWA TAIWAN PLANT PLANNED

13 April 1992

Japan's Fujisawa Pharmaceutical says its 80%-owned Taiwan-based affiliate is to start construction of a new manufacturing plant at the company's...